| __timestamp | Intra-Cellular Therapies, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 8494000000 |
| Thursday, January 1, 2015 | 87718074 | 9046000000 |
| Friday, January 1, 2016 | 93831530 | 9095000000 |
| Sunday, January 1, 2017 | 79419009 | 10554000000 |
| Monday, January 1, 2018 | 132166913 | 10775000000 |
| Tuesday, January 1, 2019 | 89124838 | 11355000000 |
| Wednesday, January 1, 2020 | 65782137 | 12340000000 |
| Friday, January 1, 2021 | 88845513 | 14277000000 |
| Saturday, January 1, 2022 | 134715000 | 14135000000 |
| Sunday, January 1, 2023 | 180142000 | 15048000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceuticals, innovation is the lifeblood of progress. Johnson & Johnson, a titan in the industry, and Intra-Cellular Therapies, Inc., a rising star, both exemplify this commitment. From 2014 to 2023, Johnson & Johnson consistently invested significantly more in research and development (R&D), with annual expenditures averaging around $11.5 billion. In contrast, Intra-Cellular Therapies, Inc. allocated an average of $97 million annually, a mere 1% of Johnson & Johnson's investment.
Despite the disparity, Intra-Cellular Therapies, Inc. has shown a remarkable growth trajectory, increasing its R&D spending by over 750% from 2014 to 2023. This underscores the company's dedication to innovation, even with limited resources. As the pharmaceutical industry continues to advance, these investments highlight the diverse strategies companies employ to drive innovation and maintain competitive edges.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Sanofi or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc.
Research and Development Investment: Incyte Corporation vs Intra-Cellular Therapies, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and CymaBay Therapeutics, Inc.